NORTH TIDE CAPITAL, LLC - Q2 2015 holdings

$1.39 Billion is the total value of NORTH TIDE CAPITAL, LLC's 22 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 70.0% .

 Value Shares↓ Weighting
SEM SellSELECT MED HLDGS CORP$210,600,000
+5.6%
13,000,000
-3.3%
15.20%
+0.8%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDadr$177,300,000
+89.7%
3,000,000
+100.0%
12.80%
+81.0%
AMED  AMEDISYS INC$158,920,000
+48.4%
4,000,0000.0%11.47%
+41.6%
KND SellKINDRED HEALTHCARE INC$101,450,000
-22.7%
5,000,000
-9.3%
7.32%
-26.2%
SVU BuySUPERVALU INC$101,125,000
+24.2%
12,500,000
+78.6%
7.30%
+18.5%
MYL  MYLAN N V$67,860,000
+14.3%
1,000,0000.0%4.90%
+9.1%
CYH SellCOMMUNITY HEALTH SYS INC NEW$62,970,000
-19.7%
1,000,000
-33.3%
4.55%
-23.4%
GILD NewGILEAD SCIENCES INC$58,540,000500,000
+100.0%
4.23%
AFAM  ALMOST FAMILY INC$49,888,000
-10.7%
1,250,0000.0%3.60%
-14.8%
OFIX SellORTHOFIX INTL N V$49,680,000
-23.1%
1,500,000
-16.7%
3.59%
-26.6%
HWAY  HEALTHWAYS INC$46,123,000
-39.2%
3,850,0000.0%3.33%
-42.0%
STJ NewST JUDE MED INC$36,535,000500,000
+100.0%
2.64%
DGX NewQUEST DIAGNOSTICS INC$36,260,000500,000
+100.0%
2.62%
MGLN  MAGELLAN HEALTH INC$35,035,000
-1.1%
500,0000.0%2.53%
-5.6%
ELOS  SYNERON MEDICAL LTD$31,860,000
-14.2%
3,000,0000.0%2.30%
-18.1%
ALGN NewALIGN TECHNOLOGY INC$31,355,000500,000
+100.0%
2.26%
IMS NewIMS HEALTH HLDGS INC$30,650,0001,000,000
+100.0%
2.21%
LH NewLABORATORY CORP AMER HLDGS$30,305,000250,000
+100.0%
2.19%
VVUS  VIVUS INC$29,500,000
-4.1%
12,500,0000.0%2.13%
-8.4%
AEGR BuyAEGERION PHARMACEUTICALS INC$18,970,000
+141.6%
1,000,000
+233.3%
1.37%
+130.6%
QSII NewQUALITY SYS INC$16,570,0001,000,000
+100.0%
1.20%
BIOS NewBIOSCRIP INC$3,630,0001,000,000
+100.0%
0.26%
FREDQ ExitFREDS INCcl a$0-638,900
-100.0%
-0.83%
BAX ExitBAXTER INTL INC$0-500,000
-100.0%
-2.59%
ESRX ExitEXPRESS SCRIPTS HLDG CO$0-500,000
-100.0%
-3.28%
GHDX ExitGENOMIC HEALTH INC$0-1,500,000
-100.0%
-3.47%
VRX ExitVALEANT PHARMACEUTICALS INTL$0-250,000
-100.0%
-3.76%
BSX ExitBOSTON SCIENTIFIC CORP$0-4,500,000
-100.0%
-6.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SELECT MED HLDGS CORP18Q3 201722.7%
SUPERVALU INC17Q2 201715.0%
SYNERON MEDICAL LTD16Q1 20175.0%
HEALTHWAYS INC15Q4 201617.5%
KINDRED HEALTHCARE INC14Q4 201611.0%
ALMOST FAMILY INC14Q3 20165.9%
VIVUS INC13Q2 20173.3%
TEVA PHARMACEUTICAL INDS LTD12Q1 201613.4%
AMEDISYS INC12Q1 201613.2%
MYLAN N V11Q3 201714.0%

View NORTH TIDE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
NORTH TIDE CAPITAL, LLC Q2 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
IRIDEX CORPFebruary 16, 2021760,0695.5%
BioScrip, Inc.Sold outFebruary 01, 201800.0%
TIVITY HEALTH, INC.August 02, 2017450,0001.1%
AMEDISYS INCJanuary 22, 20161,382,3884.1%
HEALTHWAYS, INCNovember 12, 20154,080,57311.3%
ALMOST FAMILY INCJanuary 12, 20151,078,75011.4%
VIVUS INCJanuary 05, 201510,150,0009.8%
KINDRED HEALTHCARE, INCOctober 10, 20143,390,0005.2%
ORTHOFIX INTERNATIONAL N VApril 04, 2014980,1005.4%
Syneron Medical Ltd.February 14, 20142,000,0005.7%

View NORTH TIDE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2021-02-16
SC 13G/A2018-02-01
13F-HR2017-11-14
13F-HR2017-08-14
SC 13D/A2017-08-02
13F-HR2017-05-15
42017-03-20
42017-03-10
42017-03-07
42017-03-02

View NORTH TIDE CAPITAL, LLC's complete filings history.

Compare quarters

Export NORTH TIDE CAPITAL, LLC's holdings